Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
According to Johnson & Johnson's latest financial reports and stock price the company's current Operating Margin is 22.88%. At the end of 2022 the company had an Operating Margin of 22.88%.
Year | Operating Margin | Change |
---|---|---|
2022 | 22.88% | -5.79% |
2021 | 24.29% | 21.59% |
2020 | 19.98% | -5.4% |
2019 | 21.12% | -4.29% |
2018 | 22.06% | -4.56% |
2017 | 23.12% | -16.08% |
2016 | 27.55% | 0.56% |
2015 | 27.39% | -0.98% |
2014 | 27.66% | 27.51% |
2013 | 21.69% | 5.87% |
2012 | 20.49% | 7.8% |
2011 | 19.01% | -30.92% |
2010 | 27.52% | 8.11% |
2009 | 25.45% | -4.15% |
2008 | 26.56% | 22.15% |
2007 | 21.74% | -20.52% |
2006 | 27.36% | 1.19% |
2005 | 27.03% | -0.3% |
2004 | 27.11% | 10.11% |
2003 | 24.62% | -3.8% |
2002 | 25.60% | 6.96% |
2001 | 23.93% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Novartis NVS | 17.27% | -24.52% | ๐จ๐ญ Switzerland |
Pfizer PFE | 34.61% | 51.27% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 15.60% | -31.82% | ๐บ๐ธ USA |
Medtronic MDT | 17.17% | -24.96% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | 24.66% | 7.78% | ๐บ๐ธ USA |
Sanofi SNY | 18.21% | -20.41% | ๐ซ๐ท France |
Gilead Sciences GILD | 26.84% | 17.31% | ๐บ๐ธ USA |
Stryker Corporation SYK | 16.21% | -29.15% | ๐บ๐ธ USA |
Merck MRK | 27.73% | 21.20% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 22.54% | -1.49% | ๐ฌ๐ง UK |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.